Abstract
Hypermethylation of CpG islands in gene promoter regions has been shown to be a predictive biomarker for certain diseases. Most current methods for methylation profiling are not well-suited for clinical analysis. Here, we report the development of an inexpensive device and an epigenotyping assay with a format conducive to multiplexed analysis.
| Original language | English |
|---|---|
| Pages (from-to) | 3695-3701 |
| Number of pages | 7 |
| Journal | The Analyst |
| Volume | 139 |
| Issue number | 15 |
| DOIs | |
| State | Published - 30 Jun 2014 |